Nanotechnology Now - News Story: Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

September 13th, 2005

Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

Abstract:
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.

Source:
nano.cancer.gov

Bookmark:

Related Links

Ohio State University

National Cancer Institute

Related News Press

Possible Futures

A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026

Qjump: Shallow-circuit quantum sampling guides combinatorial optimization On up to 104 superconducting qubits, Qjump assists in searching the ground states of hard Ising problems and might outperform simulated annealing on near-term quantum hardware April 17th, 2026

Rice study resolves decades-old mystery in organic light-emitting crystals: Findings reveal how molecular defects can enhance light conversion efficiency: April 17th, 2026

UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026

Nanomedicine

A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

New imaging approach transforms study of bacterial biofilms August 8th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE